Helen San's Contact Details

Helen San's Company Details

Quantgene

Santa Monica, CA, US • 50 - 99 Employees
BioTech/Drugs

UNLOCKING THE DEEP HUMAN GENOMEWe're building the future of medicine by engineering the most advanced scientific and technological innovation that unlock the Deep Human Genome.THE DEEP HUMAN GENOMEWhen a disease is developing in the body, the affected cells die and shed into the bloodstream. Life-threatening diseases like cancer leave a unique combination of mutations in the DNA of these dead cells. By investigating every single copy of cell-free DNA in a blood sample, we can gain a uniquely deep and comprehensive insight into the body's current health status. We call this comprehensive data set the DEEP HUMAN GENOME.‍To-date, no available technology has been able to fully utilize the life-saving information contained within in the Deep Human Genome.A NEW ERA OF PRECISION MEDICINEMedical technology now allows for cancer to be detected in a patient's blood through cell-free DNA (cfDNA). Quantgene has developed a method for Deep Human Genome sequencing which allows us to see mutational patterns of disease down to a single molecule. This means diseases like cancer can be detected far earlier than ever before.‍The GRIFFIN Deep Genomics Platform enables us to profile cfDNA in a patient's blood with near-absolute precision. This helps inform early cancer detection, prediction of disease onset as well as non-invasive treatment monitoring for longer healthier lives.